These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2347571)

  • 1. Patients' and caregivers' adaptation to improvement in schizophrenia.
    Mason SE; Gingerich S; Siris SG
    Hosp Community Psychiatry; 1990 May; 41(5):541-4. PubMed ID: 2347571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family response to improvement by a relative with schizophrenia.
    Conley RR; Baker RW
    Hosp Community Psychiatry; 1990 Aug; 41(8):898-901. PubMed ID: 2401481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
    Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Casey E
    Am J Psychiatry; 1988 Dec; 145(12):1532-7. PubMed ID: 3057924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
    Siris SG; Morgan V; Fagerstrom R; Rifkin A; Cooper TB
    Arch Gen Psychiatry; 1987 Jun; 44(6):533-9. PubMed ID: 3555386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using family psychoeducation when there is no family.
    Drake RE; Osher FC
    Hosp Community Psychiatry; 1987 Mar; 38(3):274-7. PubMed ID: 3557356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder.
    Siris SG; Aronson A; Sellew AP
    Biol Psychiatry; 1989 Feb; 25(4):485-8. PubMed ID: 2649158
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
    Siris SG; Bermanzohn PC; Mason SE; Shuwall MA
    Arch Gen Psychiatry; 1994 Feb; 51(2):109-15. PubMed ID: 7905256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
    Siris SG; Strahan A
    J Clin Psychiatry; 1988 Nov; 49(11):439-40. PubMed ID: 3182733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
    Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
    Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenic woman on neuroleptic medication suffers secondary depression.
    Frances A; Siris SG
    Hosp Community Psychiatry; 1988 Jan; 39(1):24-7. PubMed ID: 3338725
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
    Siris SG; Cutler J; Owen K; Mason S; Gingerich S; Lang MP
    Am J Psychiatry; 1989 Nov; 146(11):1495-7. PubMed ID: 2817126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluphenazine treatment of DSM-III-R male schizophrenic patients among the Xhosa.
    Landmark J; Merskey H; Cernovsky ZZ
    Can J Psychiatry; 1994 May; 39(4):219-22. PubMed ID: 8044729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuse.
    Siris SG; Bermanzohn PC; Mason SE; Rifkin A; Alvir JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):539-47. PubMed ID: 1641497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of postpsychotic depression to adjunctive imipramine or amitriptyline.
    Siris SG; Rifkin AE; Reardon GT
    J Clin Psychiatry; 1982 Dec; 43(12):485-6. PubMed ID: 6131064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of schizophrenia on families: one mother's point of view.
    Willis MJ
    Schizophr Bull; 1982; 8(4):617-9. PubMed ID: 7178848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emotional responses of patients with schizophrenia to their illness. Attitudes of social environment towards schizophrenes.
    Zołnierczuk-Kieliszek D; Zak B
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):74-82. PubMed ID: 12898908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of psycho-educational program on knowledge and attitude upon schizophrenia of schizophrenic patients' caregivers.
    Worakul P; Thavichachart N; Lueboonthavatchai P
    J Med Assoc Thai; 2007 Jun; 90(6):1199-204. PubMed ID: 17624218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dysphoric syndrome in schizophrenia and its implications for relapse.
    Hirsch SR; Jolley AG
    Br J Psychiatry Suppl; 1989 Jul; (5):46-50. PubMed ID: 2690890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.